Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure

Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure

Low plasma homoarginine (HA) is an emerging biomarker for cardiovascular disease and an independent predictor of mortality in patients with heart failure. Plasma levels appear to reflect cardiac dysfunction, positively correlating with ejection fraction and inversely with circulating brain natriuret...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Atzler, D, McAndrew, D, Cordts, K, Schneider, J, Zervou, S, Schwedhelm, E, Neubauer, S, Lygate, C
Formato:	Journal article
Idioma:	English
Publicado em:	American Heart Association 2017

Registros relacionados

Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure
por: McAndrew, DJ, et al.
Publicado em: (2022)

Influence of homoarginine on creatine accumulation and biosynthesis in the mouse
por: Lygate, CA, et al.
Publicado em: (2022)

Impaired cardiac contractile function in AGAT knockout mice devoid of creatine is rescued by homoarginine but not creatine
por: Faller, K, et al.
Publicado em: (2017)

Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure
por: Cao, F, et al.
Publicado em: (2020)

Cardiac insulin resistance post-myocardial infarction
por: Murray, A, et al.
Publicado em: (2003)

The amino acid homoarginine inhibits atherogenesis by modulating T-cell function
por: Nitz, K, et al.
Publicado em: (2022)

Myocardial creatine levels do not influence response to acute oxidative stress in isolated perfused heart
por: Aksentijević, D, et al.
Publicado em: (2014)

Refinement of analgesia following thoracotomy and experimental myocardial infarction using the Mouse Grimace Scale.
por: Faller, K, et al.
Publicado em: (2014)

Ribose supplementation alone or with elevated creatine does not preserve high energy nucleotides or cardiac function in the failing mouse heart
por: Faller, K, et al.
Publicado em: (2013)

Increased uncoupling protein 2 expression in heart failure, but not compensated hypertrophy, post-myocardial infarction
por: Murray, A, et al.
Publicado em: (2002)

Subtle role for adenylate kinase 1 in maintaining normal basal contractile function and metabolism in the murine heart
por: Zervou, S, et al.
Publicado em: (2021)

Surgical models of hypertrophy and heart failure: Myocardial infarction and transverse aortic constriction
por: Lygate, C
Publicado em: (2006)

Age-dependent decline in cardiac function in guanidinoacetate-N-methyltransferase knockout mice
por: Aksentijević, D, et al.
Publicado em: (2019)

Investigating cardiac energetics in heart failure.
por: Lygate, C, et al.
Publicado em: (2013)

Investigating cardiac energetics in heart failure
por: Lygate, C, et al.
Publicado em: (2013)

Cardiac troponins: from myocardial infarction to chronic disease
por: Park, KC, et al.
Publicado em: (2017)

Over-expression of mitochondrial creatine kinase in the murine heart improves functional recovery and protects against injury following ischaemia-reperfusion
por: Whittington, H, et al.
Publicado em: (2018)

Synergistic effect on cardiac energetics by targeting the creatine kinase system: in vivo application of high-resolution 31P-CMRS in the mouse
por: Maguire, ML, et al.
Publicado em: (2023)

Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury
por: Chung, W-J, et al.
Publicado em: (2016)

Elevated Myocardial Creatine Protects Against Ischemia/Reperfusion Injury by Improving Cardiac Energetics
por: Lygate, C, et al.
Publicado em: (2011)

Serial 3D echocardiograhy of postinfarct remodeling in the mouse model of myocardial infarction
por: Dawson, D, et al.
Publicado em: (2004)

Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest.
por: Little, R, et al.
Publicado em: (1985)

Characterisation of the development of cardiac lymphatic vessels and their response to myocardial infarction
por: Norman, S
Publicado em: (2017)

Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction.
por: Lygate, C, et al.
Publicado em: (2012)

Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction.
por: Laser, A, et al.
Publicado em: (1996)

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size
por: He, W, et al.
Publicado em: (2021)

Novel insights into LV remodeling after murine myocardial infarction by in vivo magnetic resonance tissue velocity mapping
por: Wiesmann, F, et al.
Publicado em: (2004)

Novel insights into LV remodeling after murine myocardial infarction by in vivo magnetic resonance tissue velocity mapping.
por: Wiesmann, F, et al.
Publicado em: (2004)

Embolic myocardial infarction in atrial fibrillation: multiple territory injury revealed by cardiac magnetic resonance.
por: Dall'Armellina, E, et al.
Publicado em: (2010)

Fibulin-3 is necessary to prevent cardiac rupture following myocardial infarction
por: Murtha, LA, et al.
Publicado em: (2023)

Cardiac conduction system regeneration prevents arrhythmias after myocardial infarction
por: Sayers, JR, et al.
Publicado em: (2025)

The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction
por: Vieira, J, et al.
Publicado em: (2018)

Mitochondrial abnormalities in chronically infarcted rat heart
por: Murray, A, et al.
Publicado em: (2004)

The creatine kinase system as a therapeutic target for myocardial ischaemia-reperfusion injury
por: Cao, F, et al.
Publicado em: (2018)

Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus.
por: Ruparelia, N, et al.
Publicado em: (2013)

Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus
por: Ruparelia, N, et al.
Publicado em: (2013)

MYOCARDIAL INFARCTION CAUSES INFLAMMATION AND LEUKOCYTE RECRUITMENT AT REMOTE SITES IN THE MYOCARDIUM AND IN THE RENAL GLOMERULUS
por: Ruparelia, N, et al.
Publicado em: (2013)

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
por: Lygate, C, et al.
Publicado em: (2003)

MLP accumulation and remodelling in the infarcted rat heart.
por: Wilding, JR, et al.
Publicado em: (2006)

Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
por: Hu, K, et al.
Publicado em: (2004)